This Could be a Game-Changer for Obesity Treatment

The world may be a step closer to successfully treating obesity with psilocybin. That’s because psilocybin activates serotonin receptors, or “nature’s own appetite suppressant,” as noted by Psychology Today. “This powerful brain chemical curbs cravings and shuts off appetite. It makes you feel satisfied even if your stomach is not full. The result is eating … Continue reading This Could be a Game-Changer for Obesity Treatment

Stocks that Could Benefit from a Study of THCV

THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and eve appetite, weight/BMI. In fact, in a study of 900 adults aged 21 and older in the U.S., InMed Pharmaceuticals Inc.’s (NASDAQ: INM) subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science, Inc.’s Radicle Energy rare cannabinoid program.  Tetrahydrocannabivarin, … Continue reading Stocks that Could Benefit from a Study of THCV

One Step Closer to Treating the Global Obesity Epidemic

NeonMind Biosciences (CSE: NEON) (OTC: NMDBF) is another step closer to treating the global obesity epidemic. At the moment, worldwide obesity has tripled since 1975, says the World Health Organization.  Plus, as of 2016, more than 1.9 billion adults were considered overweight, with 650 million considered obese.  The good news is psilocybin may be able … Continue reading One Step Closer to Treating the Global Obesity Epidemic